×

What are you searching for?




Pharmaceuticals

4 Min read

FDA PERMITS EMERGENCY USE OF COVID-19 DRUG BY ELI LILLY & CO

Published On 10 Nov 2020 04:56 PM


SHARE THIS ARTICLE  


Highlights

• Bamlanivimab developed by Eli Lilly & Co was granted emergency use authorization (EUA) by the FDA based on trial data which showcased that a one-time infusion of the treatment was successful in reducing the need for hospitalization

• This drug from Eli Lilly & Co is a monoclonal antibody, which is widely used class of biotech drugs and this case, it is manufactured copy of an antibody which is....


Tags : FDA, Eli Lilly, COVID-19, antibody drug, ,
SHARE THIS ARTICLE  

Leave a comment 

comments (0)